Cephalosporin resistance in Klebsiella pneumoniae from Nova Scotia, Canada

Diagnostic Microbiology and Infectious Disease

Volumn 56, Issue 2, 2006, Pages 197-205

  Melano, Roberto G ^a,b   Davidson, Ross J ^a,b   Musgrave, Heather L ^a,b   Forward, Kevin R ^a,b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Amp C; Cephalosporin; Cephalosporin resistance; Klebsiella pneumoniae; Outer brain protein

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; OUTER MEMBRANE PROTEIN; PORIN; SULTAMICILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SYNTHESIS; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CEPHALOSPORIN RESISTANCE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NOVA SCOTIA; PHYLOGENY;

EID: 33749254459     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.04.016     Document Type: Article

References (37)

1. Allen K.J., and Poppe C. Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by β-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. Can. J. Vet. Res. 66 (2002) 137-144
2. Ambler R.P., Coulson A.F.W., Frere J.M., Ghuysen J.M., Joris B., Forsman M., Levesque R.C., Tirabi G., and Waley S.G. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276 (1991) 269-272
3. Ardanuy C., Linares J., Dominguez M.A., Hernandez-Alles S., Benedi V.J., and Martinez-Martinez L. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob. Agents Chemother. 42 (1998) 1636-1640
4. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 (2001) 933-951
5. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39 (1995) 1211-1233
6. Chaves J., Ladona M.G., Segura C., Coira A., Reig R., and Ampurdanes C. SHV-1 beta-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45 (2001) 2856-2861
7. Doménech-Sánchez A., Martínez-Martínez L., Hernández-Allés S., Conejo M.C., Pascual A., Tomás J.M., Albertí S., and Benedí V.J. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob. Agents Chemother. 47 (2003) 3332-3335
8. Goossens H., and Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn. Microbiol. Infect. Dis. 53 (2005) 257-264
9. Gruteke P., Goessens W., van Gils J., Peerbooms P., Lemmens-den Toom N., van Santen-Verheuvel M., van Belkum A., and Verbrugh H. Patterns of resistance associated with integrons, the extended-spectrum beta-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J. Clin. Microbiol. 41 (2003) 1161-1166
10. Eisner A., Fagan E.J., Feierl G., Kessler H.H., Marth E., Livermore D.M., and Woodford N. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria. Antimicrob. Agents Chemother. 50 (2006) 785-787
11. Fevre C., Passet V., Weill F.X., Grimont P.A., and Brisse S. Variants of the Klebsiella pneumoniae OKP chromosomal beta-lactamase are divided into two main groups, OKP-A and OKP-B. Antimicrob. Agents Chemother. 49 (2005) 5149-5152
12. SHV mobilization events from the Klebsiella pneumoniae chromosome. J. Antimicrob. Chemother. 54 (2004) 69-75
13. Haeggman S., Lofdahl S., Paauw A., Verhoef J., and Brisse S. Diversity and evolution of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48 (2004) 2400-2408
14. Hernández-Allés S., Conejo M., Pascual A., Tomás J.M., Benedí V.J., and Martínez-Martínez L. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145 (1999) 673-679
15. Hernández-Allés S., Conejo M., Pascual A., Tomás J.M., Benedí V.J., and Martínez-Martínez L. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46 (2000) 273-277
16. Joris B., Ghuysen J., Dive G., Renard A., Dideberg O., Charlier P., Frère J., Kelly J., Boyington J., Moews P., and Knox J. The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family. Biochem. J. 250 (1988) 313-324
17. Kim J., Kwon Y., Pai H., Kim J.W., and Cho D.T. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol. 36 (1998) 1446-1449
18. Knothe H., Shah P., Kremery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11 (1983) 315-317
19. Martínez-Martínez L., Hernández-Alles S., Albertí S., Tomás J.M., Benedí V.J., and Jacoby G.A. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 40 (1996) 342-348
20. Masuda G., Tomioka S., and Hasegawa M. Detection of beta-lactamase production by gram-negative bacteria. J. Antibiot. (Tokyo) 29 (1976) 662-664
21. Melano R., Corso A., Petroni A., Centrón D., Orman B., Pereyra A., Moreno N., and Galas M. Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum β-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina. J. Antimicrob. Chemother. 52 (2003) 36-42
22. Mulvey M.R., Soule G., Boyd D., Demczuk W., and Ahmed R. Characterization of the first extended-spectrum beta-lactamase-producing salmonella isolate identified in Canada. J. Clin. Microbiol. 41 (2003) 460-462
23. Mulvey M.R., Bryce E., Boyd D., Ofner-Agostini M., Christianson S., Simor A.E., and Paton S. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48 (2004) 1204-1214
24. Mulvey M.R., Bryce E., Boyd D.A., Ofner-Agostini M., Land A.M., Simor A.E., and Paton S. Molecular characterization of cefoxitin resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49 (2005) 358-365
25. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. 6th ed. (2003), National Committee for Clinical Laboratory Standards, Wayne, PA
26. Nijssen S., Florijn A., Bonten M.J., Schmitz F.J., Verhoef J., and Fluit A.C. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int. J. Antimicrob. Agents 24 (2004) 585-591
27. Nuesch-Inderbinen M.T., Kayser F.H., and Hachler H. Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents Chemother. 41 (1997) 943-949
28. Pérez-Pérez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40 (2002) 2153-2162
29. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46 (2002) 1-11
30. Pitout J.D.D., Reisbig M.D., Mulvey M., Chui L., Louie M., Crowe L., Church D.L., Elsayedd S., Gregson D., Ahmed R., Tilley P., and Hanson N.D. Association between handling of pet treats and infection with Salmonella enterica serotype Newport expressing the AmpC β-lactamase, CMY-2. J. Clin. Microbiol. 41 (2003) 4578-4582
31. Poole K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56 (2005) 20-51
32. Powers R.A., Blazquez J., Weston G.S., Morosini M.I., Baquero F., and Shoichet B.K. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC β-lactamase. Protein Sci. 8 (1999) 2330-2337
33. Sader H.S., Fritsche T.R., and Jones R.N. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Diagn. Microbiol. Infect. Dis. 52 (2005) 265-273
34. Siebor E., Péchinot A., Duez J.M., and Neuwirth C. One new LEN enzyme and two new OKP enzymes in Klebsiella pneumoniae clinical isolates and proposed nomenclature for chromosomal beta-lactamases of this species. Antimicrob. Agents Chemother. 49 (2005) 3097-3098
35. Stobberingh E.E., Arends J., Hoogkamp-Korstanje J.A.A., Goessens W.H.F., Visser M.R., Buiting A.G.M., Debets-Ossenkopp Y.J., Ketel R.J., Ogtrop M.L., Sabbe L.J.M., Voorn G.P., Winter H.L.J., and van Zeijl J.H. Occurrence of extended-spectrum beta-lactamases in Dutch hospitals. Infection 27 (1999) 348-354
36. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria of bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
37. Walther-Rasmussen J., and Hoiby N. Plasmid-borne AmpC beta-lactamases. Can. J. Microbiol. 48 (2002) 479-493